Large auto-hemoinfusion versus rectal insufflation in patients with metabolic syndrome


Submitted: 12 January 2016
Accepted: 24 February 2016
Published: 5 April 2016
Abstract Views: 2774
PDF: 1615
HTML: 2134
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The metabolic syndrome is a clinical situation including a series of factors at high cardiovascular risk; the treatment with an oxygenozone gas mixture can influence all factors associated with this syndrome. The objective of the study has been to verify if the rectal insufflation could replace the large auto-hemoinfusion when treating the metabolic syndrome in those patients who, for various reasons cannot use the auto-hemoinfusion. Twenty-four individuals aged between 34 and 68 were recruited and included in the group treated with ozonated auto-hemoinfusion and other 24 individuals aged between 35 and 67 were recruited and included in the group treated with rectal insufflation of the oxygen-ozone gas mixture. According to the results obtained by means of oxygen-ozone mixture rectal insufflation, which are almost equivalent to the results obtained with the large ozonated auto-hemoinfusion, authors could conclude that the ozonated rectal insufflation can be taken into consideration as alternative method to the large auto-hemoinfusion, while treating the metabolic syndrome, in those patients difficult to manage due to the previously described reasons.

Vaiano, F., & Loprete, F. (2016). Large auto-hemoinfusion versus rectal insufflation in patients with metabolic syndrome. Ozone Therapy, 1(1), 13–16. https://doi.org/10.4081/ozone.2016.5841

Downloads

Download data is not yet available.

Citations